Metastatic Castrate-resistant Prostate (CRPC) Cancer
1 clinical trials · Condition
◉ Watch Metastatic Castrate-resistant Prostate (CRPC) Cancer
| Record | Firm | Date |
|---|---|---|
| A Study of Patient Preference Between ODM-201 and Enzalutamide in Men With Metastatic Castrate-resistant Prostate Cancer (NCT03314324) | Gustave Roussy, Cancer Campus, Grand Paris | 2017-11-29 |
Track Metastatic Castrate-resistant Prostate (CRPC) Cancer automatically
Every clearance here is in the API, with alerts when new ones post.